New approach leverages macrophages to treat traumatic brain injury

Scientists have created a new treatment for traumatic brain injury (TBI) that shrank brain lesions by 56% and significantly reduced local inflammation levels in pigs.

Safety of Less-Radical Surgery for Early Cervical Cancer Gathers More Evidence

SAN DIEGO — The safety of non-radical approaches to surgery in early, low-risk cervical cancer gained additional support from a new prospective study, though fertility

March 19, 2024

New guidelines can help alleviate unnecessary referrals related to unexpected bleeding

The British Menopause Society (BMS) has launched new, joint guidelines for GPs to help alleviate unnecessary referrals related to unexpected bleeding.

July 10, 2024

Oncolytics targets accelerated approval for oncolytic virus therapy

Oncolytics’s pelareorep is an intravenously delivered oncolytic reovirus that specifically targets cancer cells and induces inflammatory responses. Image credit: MiniStocker / Shutterstock. Oncolytics Biotech is

October 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.